EDIT vs PODD
Editas Medicine Inc (EDIT) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
EDIT currently screens at market cap $375.2M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the EDIT and PODD stock pages for the full models.
Not investment advice.